<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1471-2156-2-3.anc" start="9705" end="9711" sStart="9493" offset="212" sid="r9.normal.j.0884" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="Patients with autosomal dominant limb girdle muscular dystrophy type 1C, caused by mutations in caveolin-3 [ 19, 20], or autosomal recessive LGMD2B, caused by mutations in dysferlin, show normal dystrophin and sarcoglycan-sarcospan complex staining patterns [ 21]." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2156-2-3.anc" start="18366" end="18372" sStart="null" offset="19" sid="r9.normal.j.0982" wn="2" wnkey="normal%3:00:02::" annotator="anfahmy" text="CFEOM1 patient and normal muscle sections from extraocular muscle were stained with anti-human sarcospan and anti-human spectrin antibodies." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2156-2-3.anc" start="2600" end="2608" sStart="null" offset="133" sid="r8.family.n.0522" wn="3" wnkey="family%1:14:04::" annotator="jeneale" text="We have refined the previously published genomic structure of sarcospan more fully and screened for mutations in six families with CFEOM1." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2156-2-3.anc" start="14540" end="14545" sStart="null" offset="82" sid="r10.board.n.0383" wn="1" wnkey="board%1:14:00::" annotator="cgozo" text="This study was approved by the Children's Hospital institutional review board, and informed consent was obtained from all adult participating subjects and from parents or legal guardians of participating minors." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2156-2-3.anc" start="10348" end="10355" sStart="null" offset="63" sid="r9.appear.v.0316" wn="1" wnkey="appear%2:39:00::" annotator="brubin" text="A sarcospan null mouse has recently been generated and appears to display a normal phenotype [ 22]." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2156-2-3.anc" start="16117" end="16124" sStart="null" offset="77" sid="r11.absence.n.0556" wn="1" wnkey="absence%1:26:00::" annotator="vebatchelder" text="Reactions were analyzed on agarose gels and scored for presence or absence of the appropriately sized product." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2156-2-3.anc" start="10617" end="10624" sStart="null" offset="101" sid="r11.absence.n.0044" wn="1" wnkey="absence%1:26:00::" annotator="anfahmy" text="There may, for example, be a homologous tetraspanin protein that compensates for the absence of sarcospan in mice, but not in humans." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2156-2-3.anc" start="10730" end="10737" sStart="null" offset="64" sid="r11.absence.n.0972" wn="1" wnkey="absence%1:26:00::" annotator="adelpriore" text="There is, of course, also a difference between complete absence of a protein and a protein with an altered sequence." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2156-2-3.anc" start="10617" end="10624" sStart="null" offset="101" sid="r11.absence.n.0044" wn="1" wnkey="absence%1:26:00::" annotator="adelpriore" text="There may, for example, be a homologous tetraspanin protein that compensates for the absence of sarcospan in mice, but not in humans." />
  </sentences>
</list>